We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRE icon
2801
Costamare
CMRE
$1.77B
$6K ﹤0.01%
1,020
-4,243
-81% -$25.1K
CRNT icon
2802
Ceragon Networks
CRNT
$203M
$6K ﹤0.01%
2,772
-3,161
-53% -$6.23K
CUK
2803
DELISTED
Carnival PLC
CUK
$6K ﹤0.01%
+98
New +$6.5K
DAIO icon
2804
Data I/O
DAIO
$30.8M
$6K ﹤0.01%
+494
New +$5.85K
DDD icon
2805
3D Systems Corp
DDD
$593M
$6K ﹤0.01%
709
-5,498
-89% -$56.5K
DXJ icon
2806
WisdomTree Japan Hedged Equity Fund
DXJ
$7.29B
$6K ﹤0.01%
97
-2,403
-96% -$139K
EDIT icon
2807
Editas Medicine
EDIT
$422M
$6K ﹤0.01%
179
-1,544
-90% -$38.9K
ELDN icon
2808
Eledon Pharmaceuticals
ELDN
$266M
$6K ﹤0.01%
84
-227
-73% -$17.1K
EVH icon
2809
Evolent Health
EVH
$346M
$6K ﹤0.01%
480
-6,104
-93% -$86K
FBIO icon
2810
Fortress Biotech
FBIO
$92.7M
$6K ﹤0.01%
100
-189
-65% -$11.1K
G icon
2811
Genpact
G
$6.07B
$6K ﹤0.01%
199
-6,862
-97% -$212K
GHM icon
2812
Graham Corp
GHM
$1.22B
$6K ﹤0.01%
299
-767
-72% -$15.5K
HISF icon
2813
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$99M
$6K ﹤0.01%
119
+7
+6% +$357
HNRG icon
2814
Hallador Energy
HNRG
$696M
$6K ﹤0.01%
1,064
-4,781
-82% -$26.9K
HUBG icon
2815
HUB Group
HUBG
$2.91B
$6K ﹤0.01%
236
-12,144
-98% -$267K
INO icon
2816
Inovio Pharmaceuticals
INO
$70M
$6K ﹤0.01%
113
-536
-83% -$33.2K
INSE icon
2817
Inspired Entertainment
INSE
$185M
$6K ﹤0.01%
622
-408
-40% -$4.39K
INSM icon
2818
Insmed
INSM
$21.5B
$6K ﹤0.01%
192
-1,964
-91% -$58K
JAKK icon
2819
Jakks Pacific
JAKK
$297M
$6K ﹤0.01%
229
-17
-7% -$471
MPLX icon
2820
MPLX
MPLX
$60.1B
$6K ﹤0.01%
+176
New +$6.2K
MTG icon
2821
MGIC Investment
MTG
$6.27B
$6K ﹤0.01%
435
-45,401
-99% -$638K
MWA icon
2822
Mueller Water Products
MWA
$4.13B
$6K ﹤0.01%
490
-19,969
-98% -$246K
NODK icon
2823
NI Holdings
NODK
$315M
$6K ﹤0.01%
339
-1,114
-77% -$19.5K
OUT icon
2824
Outfront Media
OUT
$5.64B
$6K ﹤0.01%
+252
New +$5.9K
PAG icon
2825
Penske Automotive Group
PAG
$14.2B
$6K ﹤0.01%
122
-156
-56% -$7.35K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.